Literature DB >> 8478864

OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.

P Tugwell1, M Boers.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8478864

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  34 in total

1.  Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis.

Authors:  T Uhlig; T K Kvien; J L Jensen; T Axéll
Journal:  Ann Rheum Dis       Date:  1999-07       Impact factor: 19.103

Review 2.  Impairment measures in rheumatic disorders for rehabilitation medicine and allied health care: a systematic review.

Authors:  Raymond A H M Swinkels; Lex M Bouter; Rob A B Oostendorp; Cornelia H M van den Ende
Journal:  Rheumatol Int       Date:  2005-06-24       Impact factor: 2.631

Review 3.  Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.

Authors:  Rebecca Grainger; Nicola Dalbeth; Helen Keen; Laura Durcan; N Lawrence Edwards; Fernando Perez-Ruiz; Cesar Diaz-Torne; Jasvinder A Singh; Dinesh Khanna; Lee S Simon; William J Taylor
Journal:  J Rheumatol       Date:  2015-02-01       Impact factor: 4.666

4.  [Patient perspectives in outcome research : Development of a focus group concept for collating patient perspectives on determination of effectiveness of multimodal pain therapy - A pilot study].

Authors:  K Neustadt; S Deckert; R Heineck; C Kopkow; A Preißler; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2017-04       Impact factor: 1.107

5.  Content and quality of 10,000 controlled trials in schizophrenia over 60 years.

Authors:  Jose Miyar; Clive E Adams
Journal:  Schizophr Bull       Date:  2012-01-30       Impact factor: 9.306

Review 6.  Setting the research agenda for improving health care in musculoskeletal disorders.

Authors:  Rachelle Buchbinder; Chris Maher; Ian A Harris
Journal:  Nat Rev Rheumatol       Date:  2015-06-16       Impact factor: 20.543

7.  Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease.

Authors:  Emil Ter Veer; L Bengt van Rijssen; Marc G Besselink; Rosa M A Mali; Jordan D Berlin; Stefan Boeck; Franck Bonnetain; Ian Chau; Thierry Conroy; Eric Van Cutsem; Gael Deplanque; Helmut Friess; Bengt Glimelius; David Goldstein; Richard Herrmann; Roberto Labianca; Jean-Luc Van Laethem; Teresa Macarulla; Jonathan H M van der Meer; John P Neoptolemos; Takuji Okusaka; Eileen M O'Reilly; Uwe Pelzer; Philip A Philip; Marcel J van der Poel; Michele Reni; Werner Scheithauer; Jens T Siveke; Chris Verslype; Olivier R Busch; Johanna W Wilmink; Martijn G H van Oijen; Hanneke W M van Laarhoven
Journal:  Lancet Oncol       Date:  2018-03       Impact factor: 41.316

8.  Factors related to change in global health after group physical therapy in ankylosing spondylitis.

Authors:  A Hidding; S van der Linden
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

9.  Three lessons from a randomized trial of massage and meditation at end of life: patient benefit, outcome measure selection, and design of trials with terminally ill patients.

Authors:  Lois Downey; Ruth A Engelberg; Leanna J Standish; Leila Kozak; William E Lafferty
Journal:  Am J Hosp Palliat Care       Date:  2009-04-24       Impact factor: 2.500

10.  Redundancy of conventional articular response variables used in juvenile chronic arthritis clinical trials.

Authors:  N Ruperto; E H Giannini
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.